AcuFocus Kamra Inlay Gets Mixed FDA Panel Vote
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Ophthalmic Devices Panel narrowly found the benefits to outweigh the risks for AcuFocus’ Kamra inlay for improving near vision of presbyopics, but voted “no” on the product’s safety profile.